Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts

Fig. 4

Western blot analysis of ex-mouse tumors. Western blot analysis of (p)PDGFRA/B, (p)EGFR and downstream MAPK and PI3K/AKT signaling pathways, performed on three different tumors per treatment group, collected after the 2-week treatment period. *MG-63 osteosarcoma cells stimulated with PDGF-BB, #MG-63 osteosarcoma cells stimulated with PDGF-AA, **HEK cells

Back to article page